STONY BROOK, N.Y., July 31 /PRNewswire-FirstCall/ -- Applied DNA Sciences, Inc. (OTC Bulletin Board: APDN), a DNA security solutions company, today announced that its co-development project with Stony Brook University has been extended for at least a year based upon progress generated since the project began in February 2006. The initial grants funded the further development of APDN's DNA library and the completion of additional prototypes that will allow APDN to extend its platform to additional industries. APDN uses DNA encryption to authenticate products and identify counterfeits. Funding awarded to this project by the University's Center for Biotechnology ("Center"), a New York State Center for Advanced Technology, now totals $158,011.54. Dr. Clinton T. Rubin, Director, Center for Biotechnology and Professor and Chair, Department of Biomedical Engineering, Stony Brook University, stated, "We are very pleased to continue to facilitate the collaboration between the Center and Applied DNA Sciences. This grant will help continue to provide resources and support to fuel the growth and commercialization of forensic- based technologies." Leading this project on behalf of the Center is Dr. Sanford Simon, Professor of Biochemistry, Cell Biology, and Pathology, Stony Brook University, and a director of APDN, "The first stage of this project, which is essentially creating a library of unique sequences of plant DNA, has been completed." "Thanks to the support from the Center for Biotechnology for this project, we are able to extend our uses of the company's unique plant chimers into new commercial markets that have been heretofore inaccessible for DNA markings. We are now expanding our reach from consumer products and art to pharmaceuticals. The first grant has helped APDN to assemble prototypes of products that we can demonstrate to our clients," stated Dr. Benjamin Liang, Strategic Technology Officer for Applied DNA Sciences. About Applied DNA Sciences, Inc. Applied DNA Sciences, Inc. (APDN) develops proprietary DNA-embedded security solutions that use plant DNA to verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion into physical plant and databases. Our common stock is registered under Section 12(g) of the Securities Exchange Act of 1934 and is listed on the Over-The-Counter Bulletin Board under the symbol "APDN". Contact: MeiLin Wan, Applied DNA Sciences, Inc., 25 Health Sciences Drive, Stony Brook, New York 11790; Tel: 631-444- 6370; Fax: 631-444.8848 http://www.ADNAS.com. The statements made by Applied DNA Sciences, Inc. may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe the Company's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA Sciences, Inc. Actual results could differ materially from those projected due to changes in interest rates, market competition, changes in the local and national economies, and various other factors detailed from time to time in Applied DNA Sciences' SEC reports and filings, including our Annual Report on Form 10-KSB, filed on January 12, 2006, our subsequent Quarterly Reports on Form 10-QSB, and our Current Reports on Form 8-K. The Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
SOURCE Applied DNA Sciences, Inc.